shIDO-ST

N/A

Report date: 2025/01/15 20:00:32

Base Information

Drug NameshIDO-ST

Drug Alias NameN/A

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > short hairpin RNAVaccines > Development/production technology > Recombinant vector vaccine

Mechanisms of ActionIndoleamine 2,3-dioxygenase inhibitors

TargetsIndoleamine 2,3-dioxygenase

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCity of Hope

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCity of Hope Tara Immuno-Oncology LLC

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A